Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva. Abstract. PASQUALOTTO, Alessandro Comarú; MATTOS, Alice J.Z. de and ROCHA, Marineide Melo. Leucoencefalopatia multifocal progressiva confirmada por. A leucoencefalopatia multifocal progressiva (LMP) é uma doença desmielinizante do sistema nervoso central (SNC) causada pela reativação do vírus JC (JCV).

Author: Voodootaxe Akizilkree
Country: Cambodia
Language: English (Spanish)
Genre: Life
Published (Last): 3 January 2013
Pages: 112
PDF File Size: 11.85 Mb
ePub File Size: 19.30 Mb
ISBN: 143-8-53987-832-3
Downloads: 21759
Price: Free* [*Free Regsitration Required]
Uploader: Nern

Synonyms or Alternate Spellings: J Neurol Neurosurg Psychiatry. The breakdown of myltifocal is commensurate with the degree of immunocompromise. The patient cleared the virus and had no further neurological deterioration. Overall, the incidence of PML in Natalizumab-treated patients was estimated as 2.

The clinical picture of PML varies according to the patterns of demyelination. Restoration of the adaptive immune response is crucial in controlling JCV replication and stabilizing disease. Improvement in immunosuppression seems to be beneficial and can lead to stabilization or regression of the disease in follow-up on imaging exams.

Progressive multifocal leukoencephalopathy in non-HIV patient

In multiple sclerosis, efficacy may be related to blockade of T-lymphocyte migration into the central nervous system There are no specific antivirals drugs against JCV.

November Learn how and when to remove this template message. N Engl J Med ; PML occurs almost exclusively in patients with severe immune deficiencymost commonly among patients with acquired immune deficiency syndrome AIDSbut people on chronic immunosuppressive medications including chemotherapy are also at increased risk of PML, such as patients with transplants, Hodgkin’s lymphomamultiple sclerosispsoriasisand other autoimmune diseases. A review of leucoencefalopaita literature in revealed only cases, most of them associated with hematological diseases 4.


The virus causes disease lfucoencefalopatia when the immune system has been severely weakened. Corticosteroids have been used by several groups in order to modulate inflammatory reaction and avoid a catastrophic deterioration, but their use is controversial since they can also potentiate immunosuppression and blunt the JCV specific cellular leuvoencefalopatia response Progressive multifocal leukoencephalopathy in patients with HIV infection.

Progressive multifocal leukoencephalopathy a review leucoencefalkpatia the neuroimaging multifoczl and differential diagnosis. D ICD – Since restoration of the cellular immune response against JCV is the best predictor of survival in PML 8the introduction of combined antiretroviral drugs led to a significant improvement in mortality. Views Read Edit View history.

Leucoencefalopatia Multifocal Progressiva (PML)

American Society for Microbiology. IRIS is defined as a paradoxical worsening of preexisting infectious processes or development of new symptoms following the initiation of highly active antiretroviral therapy HAART in HIV-infected individuals.

Subcortical frontal and parieto-occipital regions are common locations. The virus remains latent mainly in the kidneys and lymphoid organs and is reactivated and spreads to the brain, almost exclusively in the setting of advanced immunosuppression.

MuV Mumps Cytomegalovirus Cytomegalovirus esophagitis. However, isolated posterior fossa involvement has also been reported Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: In a study with a cohort of 98 PML patients from Spain, the use of antiretroviral regimens containing protease inhibitors were associated with reduction in mortality Shackelton; Andrew Rambaut; Oliver G. The most frequently encountered symptoms include:. Since diagnosis, he had remained asymptomatic and in clinical follow-up, under no specific therapy.


However, basal ganglia, brainstem and cerebellum also can be involved.

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. However, due to its biological properties, it remains active for as long as three months and during this period, PML can progress.

Progressive multifocal leukoencephalopathy | Radiology Reference Article |

The subcortical lesions tend to involve U-fibers. This is in contradistinction to more symmetrical hypoattenuation seen in HIV encephalopathy. The first step in the treatment is to discontinue Natalizumab.

Unsourced material may be challenged and removed. J Neurol Neurosurg Psych Apr It usually follows the rapid restoration of the immune function and is often self-limited, but progresiva can be fatal or associated with permanent sequelae.

It refers to a coalescent bilateral parieto-occipital T2 and FLAIR hyperintense lesion with involvement of the splenium of the corpus callosum reminiscent of a barbell see case. PML destroys oligodendrocytes and produces intranuclear inclusions.

Read it at Google Books – Find it at Amazon.